STOCK TITAN
  1. Home
  2. Sec-filings
  3. ONCO
  4. [Form 4] Onconetix, Inc. Insider Trading Activity

[Form 4] Onconetix, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ONCO logo
Onconetix

NASDAQ:ONCO

ONCO Rankings

#11278 Ranked by Market Cap
N/A Ranked by Dividends

ONCO Latest News

Jul 16, 2025
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
Jun 16, 2025
Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel
Jun 11, 2025
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
May 22, 2025
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
Apr 30, 2025
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

ONCO Latest SEC Filings

Jul 16, 2025
[SCHEDULE 13D/A] Onconetix, Inc. SEC Filing
Jul 16, 2025
[8-K] Onconetix, Inc. Reports Material Event

ONCO Stock Data

2.28M
460.92k
35.48%
2.8%
1.44%
Biotechnology
Pharmaceutical Preparations
Link
United States
CINCINNATI